Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial–mesenchymal transition by stabilizing YAP1
Cancer Medicine · 2023
DOI: 10.1002/cam4.6074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Jianyong Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Second Affiliated Hospital of Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Bone Neoplasms, Osteosarcoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Osteosarcoma (OS) is a fatal adolescent tumor, which is susceptible to remote metastases at an early stage, and its treatment remains a major challenge. ubiquitin‐specific protease 10 (USP10) is primarily located in the cytoplasm and can therefore deubiquitinate various cytoplasmic proteins. However, the expression and mechanism of USP10 in OS remain ambiguous. The aim of this study was to explore how USP10 affects Yes‐associated protein1 (YAP1) to influence the metastasis and epithelial–mesenchymal transition (EMT).
Methods
Western blotting, qRT‐PCR, and immunohistochemical (IHC) analyses were performed to evaluate USP10 and YAP1 levels. Using wound healing and transwell tests, the roles and molecular pathways of USP10 and YAP1 ability to migrate and invade of OS were investigated, and cell morphological alterations were examined using phalloidin staining.
Results
Our results indicated that USP10, a new type of deubiquitinating protease, is increased in OS tissues and cells contrasted with adjacent healthy tissues. Overexpression of USP10 correlated with tumor size, distant metastasis, and TNM stage, and was an independent factor of poor prognosis in OS patients. Also, USP10 expression is closely connected with the incident of OS metastasis and tumor size. Functional assays revealed that USP10 knockdown suppressed cell migrating and invading ability and inhibited the EMT of OS cells in vivo and in vitro. In addition, we showed that USP10 knockdown decreased the levels of YAP1, which is an important positive regulator of migration and invasion in many cancers. We also found a significant positive correlation between USP10 and YAP1 levels, further demonstrating that USP10‐induced migration and EMT are based on YAP1 in OS cells. In a mechanistic way, USP10 stabilizes the expression of YAP1 by mediating its deubiquitination in OS cells.
Conclusion
Together, this study showed that USP10 can directly interact with YAP1 to reduce ubiquitinated YAP1, thereby stabilizing its protein levels and affecting EMT and distant metastasis in OS cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Second Affiliated Hospital of Nanchang University, Nanchang, China.
- Second Affiliated Hospital of Nanchang University, Nanchang, China.
- Department of Oncology, Second Affiliated Hospital of Nanchang University, Nanchang, China.
ORCID-Profile: Liang Hao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Deng, J., Yi, X., Feng, Z., Peng, J., Li, D., Li, C., Deng, B., Liu, S., Sahu, S., & Hao, L. (2023). Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial–mesenchymal transition by stabilizing YAP1. Cancer Medicine. https://doi.org/10.1002/cam4.6074
Vancouver
Deng J, Yi X, Feng Z, Peng J, Li D, Li C, et al. Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial–mesenchymal transition by stabilizing YAP1. Cancer Medicine. 2023. doi:10.1002/cam4.6074
BibTeX
@article{Deng2023,
author = {Deng, Jianyong and Yi, Xuan and Feng, Zuxi and Peng, Jie and Li, Dan and Li, Chen and Deng, Binbin and Liu, Shuaigang and Sahu, Souradeep and Hao, Liang},
title = {Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial–mesenchymal transition by stabilizing YAP1},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.6074}
}
EUVIMED